A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0001)
Clinical trial NCT05354453 · COMPLETED
Trial details
- NCT number
- NCT05354453
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2023-06-14
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.